Interleukin-34 Induces Cc-chemokine Ligand 20 in Gut Epithelial Cells.

BACKGROUND AND AIM Production of chemokines by intestinal epithelial cells is a key step in the amplification of the destructive immune-inflammatory response in patients with inflammatory bowel diseases [IBD]. In this study, we examined whether intestinal epithelial cells express macrophage colony-stimulating factor receptor 1 [M-CSFR-1], the functional receptor of interleukin-34 [IL-34], a cytokine that is over-produced in IBD and supposed to sustain inflammatory pathways. METHODS M-CSFR-1 expression was evaluated in intestinal samples of IBD patients, controls, and colon epithelial cell lines by real-time polymerase chain reaction [PCR], immunohistochemistry, and western blotting. DLD-1 cells were stimulated with IL-34 in the presence or absence of MAP kinase inhibitors, chemokine induction was assessed by real-time PCR and enzyme-linked immunosorbent assay [ELISA], and mitogen-activated protein (MAP) kinase activation was monitored by western blotting. The effect of a neutralising IL-34 antibody on CC chemokine ligand (CCL) 20 synthesis was tested in ex vivo organ cultures of IBD mucosal explants. RESULTS Enhanced expression of M-CSFR-1 RNA transcripts was seen in inflamed mucosa of IBD patients as compared with controls. Immunohistochemical analysis confirmed up-regulation of M-CSFR-1 in IBD and showed that both epithelial and lamina propria mononuclear cells expressed this receptor. Stimulation of DLD-1 with IL-34 increased CCL20 production through an ERK1/2-dependent mechanism. Consistently, treatment of IBD explants with anti-IL-34 reduced CCL20 production. CONCLUSIONS These data show that intestinal epithelial cells are a target of IL-34 and suggest that this cytokine contributes to mediating the cross-talk between epithelial cells and immune cells in IBD.

[1]  M. Colonna,et al.  IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease. , 2015, The Journal of clinical investigation.

[2]  F. Caprioli,et al.  Interleukin-34 sustains inflammatory pathways in the gut. , 2015, Clinical science.

[3]  E. Boström,et al.  Interleukin 34: a new modulator of human and experimental inflammatory bowel disease , 2015, Clinical science.

[4]  P. Roingeard,et al.  IL‐34 and macrophage colony‐stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells , 2014, Hepatology.

[5]  M. Mehler,et al.  Receptor-type Protein-tyrosine Phosphatase ζ Is a Functional Receptor for Interleukin-34* , 2013, The Journal of Biological Chemistry.

[6]  F. Ginhoux,et al.  Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. , 2012, Immunity.

[7]  L. Williams,et al.  The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1. , 2012, Biochimica et biophysica acta.

[8]  M. Diamond,et al.  IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia , 2012, Nature Immunology.

[9]  M. Starovasnik,et al.  Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R. , 2012, Structure.

[10]  H. Lehr,et al.  CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell-mediated protection from colitis. , 2012, Gastroenterology.

[11]  J. Monahan,et al.  Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts , 2011, Rheumatology International.

[12]  W. Strober,et al.  Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. , 2011, Gastroenterology.

[13]  S. Okada,et al.  IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation , 2010, Cell Death and Differentiation.

[14]  J. Monahan,et al.  Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood. , 2010, Cytokine.

[15]  G. Kolios,et al.  Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies , 2010, Clinical and experimental immunology.

[16]  L. Williams,et al.  Functional overlap but differential expression of CSF‐1 and IL‐34 in their CSF‐1 receptor‐mediated regulation of myeloid cells , 2010, Journal of leukocyte biology.

[17]  D. Heymann,et al.  Interleukin‐34 is expressed by giant cell tumours of bone and plays a key role in RANKL‐induced osteoclastogenesis , 2010, The Journal of pathology.

[18]  L. Williams,et al.  Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome , 2008, Science.

[19]  P. Mannon,et al.  The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.

[20]  A. Satir,et al.  Comparison of RANTES expression in Crohn’s disease and ulcerative colitis: an aid in the differential diagnosis? , 2006, Journal of Clinical Pathology.

[21]  S. Hanauer,et al.  Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities , 2006, Inflammatory bowel diseases.

[22]  R. Wu,et al.  Up-Regulation of CC Chemokine Ligand 20 Expression in Human Airway Epithelium by IL-17 through a JAK-Independent but MEK/NF-κB-Dependent Signaling Pathway1 , 2005, The Journal of Immunology.

[23]  A. Gasbarrini,et al.  Chemokines in inflammatory bowel disease , 2005, Journal of Clinical Pathology.

[24]  S. Aspengren,et al.  PAR-2 activation in intestinal epithelial cells potentiates interleukin-1beta-induced chemokine secretion via MAP kinase signaling pathways. , 2005, Cytokine.

[25]  I. Williams,et al.  Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury , 2005, Gut.

[26]  C. Pothoulakis,et al.  MEK Is a Key Modulator for TLR5-induced Interleukin-8 and MIP3α Gene Expression in Non-transformed Human Colonic Epithelial Cells* , 2004, Journal of Biological Chemistry.

[27]  J. Van Damme,et al.  The CC chemokine CCL20 and its receptor CCR6. , 2003, Cytokine & growth factor reviews.

[28]  G. Bouma,et al.  The immunological and genetic basis of inflammatory bowel disease , 2003, Nature Reviews Immunology.

[29]  Lung-Chi Chen,et al.  Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. , 2003, American journal of respiratory cell and molecular biology.

[30]  Penny A. Johnson,et al.  Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease , 2003, The Journal of pathology.

[31]  L. Crepaldi,et al.  CCL20/macrophage inflammatory protein‐3α production in LPS‐stimulated neutrophils is enhanced by the chemoattractant formyl‐methionyl‐leucyl‐phenylalanine and IFN‐γ through independent mechanisms , 2002, European journal of immunology.

[32]  L. Mayer,et al.  Colonic epithelial cells are a major site of macrophage inflammatory protein 3α (MIP-3α) production in normal colon and inflammatory bowel disease , 2002, Gut.

[33]  T. Macdonald,et al.  Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. , 2001, The Journal of clinical investigation.

[34]  S W Binder,et al.  CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. , 2001, Gastroenterology.

[35]  L. Mayer,et al.  The role of epithelial cells in immune regulation in the gut. , 2001, Seminars in immunology.

[36]  O. Berezovska,et al.  Expression of colony stimulating factor‐1 receptor (CSF‐1R) by CNS neurons in mice , 1999, Journal of neuroscience research.

[37]  G. Coukos,et al.  Macrophage-Colony Stimulating Factor (M-CSF) Regulates the Expression of Fibronectin and Its α5 Integrin Receptor in Human Trophoblasts. , 1998, Endocrinology.

[38]  C. Fiocchi.  Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. , 1997, American journal of physiology. Gastrointestinal and liver physiology.

[39]  P. Pavli,et al.  Enhanced expression and production of monocyte chemoattractant protein‐1 in inflammatory bowel disease mucosa , 1996, Journal of leukocyte biology.

[40]  R. Rodriguiz,et al.  Functions of the M-CSF receptor on osteoclasts. , 1996, Bone.

[41]  T. Kadowaki,et al.  Expression of M-CSF receptor encoded by c-fms on smooth muscle cells derived from arteriosclerotic lesion. , 1992, The Journal of biological chemistry.

[42]  E. Stanley,et al.  Distribution of cells bearing receptors for a colony-stimulating factor (CSF-1) in murine tissues , 1981, The Journal of cell biology.

[43]  T. Macdonald,et al.  Blocking Smad 7 restores TGF-b 1 signaling in chronic inflammatory bowel disease , 2018 .

[44]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[45]  T. Macdonald,et al.  A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells. , 2007, Gastroenterology.

[46]  O. Kang,et al.  Inhibitory effect of luteolin on TNF-alpha-induced IL-8 production in human colon epithelial cells. , 2005, International immunopharmacology.

[47]  O. Kang,et al.  Inhibitory effect of luteolin on TNF-α-induced IL-8 production in human colon epithelial cells , 2005 .

[48]  H. Tilg,et al.  Increased Expression of CCL20 in Human Inflammatory Bowel Disease , 2004, Journal of Clinical Immunology.

[49]  L. Mayer,et al.  Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. , 2002, Gut.

[50]  G. Coukos,et al.  Macrophage-colony stimulating factor (M-CSF) regulates the expression of fibronectin and its alpha5 integrin receptor in human trophoblasts. , 1998, Endocrinology.

[51]  R. Macdermott,et al.  Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. , 1995, Gastroenterology.

[52]  J. Pollard,et al.  Expression of the colony-stimulating factor-1 receptor (c-fms proto-oncogene product) in the human uterus and placenta. , 1992, Biology of reproduction.